Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ENRICH-AF: Edoxaban for intracranial hemorrhage survivors with atrial fibrillation
2024-518508-31-00Phase 4Completed
- Sponsor
- Hamilton Health Sciences Corporation, PHRI Population Health Research Institute International
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 19
01
Overview
Phase 4, randomised, open-label trial in Atrial fibrillation (AFib) and intracerebral hemorrhage (ICH) comparing Edoxaban (Lixiana) with Standard-of-care control (2 arms). Started Dec 2024; status: completed.
02
Drugs
edoxaban
03
Conditions
Atrial fibrillation (AFib)intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2024-518508-31-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518508-31-00.